New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 3, 2014
11:15 EDTQUREuniQure announces analysis of six-year follow-up data for Glybera
uniQure announced the full analysis of the six-year follow-up data for patients treated once with Glybera, uniQure's gene therapy product for the treatment of lipoprotein lipase deficiency. Glybera is approved in the EU as a treatment for LPLD, a potentially life-threatening, orphan metabolic disease that results in patients' inability to process fat in the blood after a meal. LPLD patients eligible for Glybera treatment suffer from reoccurring and often severe pancreatitis events leading to recurrent admissions to hospitals and intensive care units.
News For QURE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 27, 2014
06:50 EDTQUREuniQure and AIPGENE Consortium complete Phase I trial for AAV5-PBGD
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use